Julie Carrera and colleagues found hundreds of contract manufacturing companies capable of producing dual use chemicals and biological agents. Almost all companies are located in countries where they are subject to strategic trade controls.
All stakeholders agree publicly that innovation and governance of emerging technologies should be done responsibly. However, the international debate on who should do what to contribute to this lofty goal is nowhere near a solution.
Conor Douglas and Dirk Stemerding: Special Issue Systems and Synthetic Biology 2013 Volume 7 Issue 3
Synthetic biology represents a fusion of the pragmatic and the idealistic, which is motivated by the drive for a better understanding of biological processes, a
The article provides an overview on recent progress in biomedical and biotechnological applications of synthetic genomics and synthetic biology as well as on arguments and evidence related to their possible benefits and risks.